Comparison of Oxybutynin and its Active Metabolite, N-Desethyl-Oxybutynin, in the Human Detrusor and Parotid Gland-Reference-Cited by-同舟云学术

Comparison of Oxybutynin and its Active Metabolite, N-Desethyl-Oxybutynin, in the Human Detrusor and Parotid Gland

Published:1997-03 Issue:3 Volume:157 Page:1093-1097
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Waldeck Kristian¹,Larsson Bengt¹,Andersson Karl-Erik¹

Affiliation:

1. Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Oxybutynin: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability;Yarker;Drugs Aging,1995

2. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues;Andersson;Pharmacol. Rev.,1993

3. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins;Wang;J. Pharmacol. Exp. Ther.,1995

4. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors;Poli;Gen. Pharmacol.,1992

5. Metabolism of oxybutynin: establishment of desethyloxybutynin and oxybutynin N-oxide formation in rat liver preparations using deuterium substitution and gas chromatographic mass spectrometric analysis;Lindeke;Biomed. Mass. Spec.,1981

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. Drug Treatment;Handbook of Neurourology;2023

3. Drug Treatment;Handbook of Neurourology;2023

4. Intravesical sustained release system of lidocaine and oxybutynin results from in vitro and animal study;International Urology and Nephrology;2022-07-03

5. Medical Therapy with Antimuscarinics and ß3-Agonists;Female Urinary Incontinence;2022